Farmaco: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Farmaco
Largest movements
- Receivables within one year +€13,570
up €13,570 (+984%), from €1,379 to €14,949
of which Other amounts receivable: +€9,685
- Deferred charges and accrued income -€893
down €893 (-85.6%), from €1,043 to €150
- Tangible fixed assets -€638
down €638 (-43.9%), from €1,452 to €814
of which Furniture and vehicles: -€352
- Cash +€359
up €359 (+34.1%), from €1,052 to €1,412
mainly Net result for the year (+€14,717) and Other debts (+€10,251)
- Other debts +€10,251
up €10,251 (+284%), from €3,604 to €13,855
- Tax, wage and social debts +€1,432
up €1,432 (+339%), from €423 to €1,856
- Profit (loss) carried forward +€862
up €862, from -€862 to €0
- Trade debts -€407
down €407 (-55.2%), from €737 to €330
- Accrued charges and deferred income +€258
up €258 (+1,011%), from €26 to €284
- Gross operating margin +€16,792
up €16,792 (+315%), from €5,337 to €22,129
- Taxes +€4,011
up €4,011 (+325%), from €1,233 to €5,244
- Depreciation -€3,626
down €3,626 (-85.0%), from €4,264 to €638
- Financial charges +€1,128
up €1,128 (+2,052%), from €55 to €1,183
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €4,927 | €17,325 | +€12,398 | +252% |
| Fixed assets | 21/28 | €1,452 | €814 | -€638 | -43.9% |
| Tangible fixed assets | 22/27 | €1,452 | €814 | -€638 | -43.9% |
| Plant, machinery and equipment | 23 | €604 | €318 | -€286 | -47.3% |
| Furniture and vehicles | 24 | €848 | €496 | -€352 | -41.5% |
| Current assets | 29/58 | €3,475 | €16,511 | +€13,036 | +375% |
| Amounts receivable within one year | 40/41 | €1,379 | €14,949 | +€13,570 | +984% |
| Trade receivables | 40 | €953 | €4,837 | +€3,884 | +408% |
| Other amounts receivable | 41 | €427 | €10,112 | +€9,685 | +2,270% |
| Cash at bank and in hand | 54/58 | €1,052 | €1,412 | +€359 | +34.1% |
| Deferred charges and accrued income | 490/1 | €1,043 | €150 | -€893 | -85.6% |
| Total equity and liabilities | 10/49 | €4,927 | €17,325 | +€12,398 | +252% |
| Equity | 10/15 | €138 | €1,000 | +€862 | +626% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€862 | €0 | +€862 | |
| Amounts payable | 17/49 | €4,789 | €16,325 | +€11,536 | +241% |
| Amounts payable within one year | 42/48 | €4,764 | €16,041 | +€11,277 | +237% |
| Trade debts | 44 | €737 | €330 | -€407 | -55.2% |
| Suppliers | 440/4 | €737 | €330 | -€407 | -55.2% |
| Taxes, remuneration and social security | 45 | €423 | €1,856 | +€1,432 | +339% |
| Taxes | 450/3 | €423 | €1,856 | +€1,432 | +339% |
| Other amounts payable | 47/48 | €3,604 | €13,855 | +€10,251 | +284% |
| Accrued charges and deferred income | 492/3 | €26 | €284 | +€258 | +1,011% |
| Non-recurring operating income | 76A | - | €6,198 | +€6,198 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,264 | €638 | -€3,626 | -85.0% |
| Other operating charges | 640/8 | €521 | €567 | +€46 | +8.9% |
| Gross operating margin | 9900 | €5,337 | €22,129 | +€16,792 | +315% |
| Operating profit (loss) | 9901 | €552 | €20,924 | +€20,372 | +3,693% |
| Financial income | 75/76B | - | €221 | +€221 | |
| Recurring financial income | 75 | - | €221 | +€221 | |
| Financial charges | 65/66B | €55 | €1,183 | +€1,128 | +2,052% |
| Recurring financial charges | 65 | €55 | €1,183 | +€1,128 | +2,052% |
| Profit (loss) for the period before taxes | 9903 | €497 | €19,962 | +€19,465 | +3,919% |
| Income taxes | 67/77 | €1,233 | €5,244 | +€4,011 | +325% |
| Profit (loss) for the period | 9904 | -€737 | €14,717 | +€15,454 | |
| Profit (loss) for the period to be appropriated | 9905 | -€737 | €14,717 | +€15,454 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.